← FDA Drug Approvals (Drugs@FDA)

PARSABIV

NDA · New Drug Application · Sponsor: KAI PHARMS INC · Approved 2017-02-07

Drug application

FDA Application #

NDA208325

Application type

New Drug Application

Brand name

PARSABIV

Generic name

ETELCALCETIDE

Active ingredients

ETELCALCETIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

KAI PHARMS INC

Manufacturer

Amgen, Inc

First approval

2017-02-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown